Matinas biopharma selected to participate in the b. riley fall 2021 growth biotech best ideas series

Bedminster, n.j., oct. 25, 2021 (globe newswire) -- matinas biopharma holdings, inc. (nyse amer: mtnb), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (lnc) platform delivery technology, today announced that matinas biopharma has been selected for inclusion in the b. riley fall 2021 growth biotech best ideas series. as part of the series, jerome d. jabbour, chief executive officer of matinas, and other members of the matinas leadership team will participate in a fireside chat on tuesday, november 23, 2021.
MTNB Ratings Summary
MTNB Quant Ranking